Alchelyst, the Ireland-based investor solutions and infrastructure partner for private markets asset managers, has appointed three managers to its leadership team:
Jeff Dorigan, MD, head of U.S. sales, spent eight years at Brown Brothers Harriman. Karl McDonald, MD, transformation, was previously global head of hedge fund operations at BNY. Sinéad O’Sullivan, MD, investor solutions, was most recently director of investor services at Viking Global Investors.